Synthesis and activity of piperazine-containing antirhinoviral agents and crystal structure of SDZ 880-061 bound to human rhinovirus 14

Journal of Molecular Biology

Volumn 259, Issue 1, 1996, Pages 120-134

  Oren, Deena A ^a   Zhang, Anqiang ^a,c   Nesvadba, Hans ^b   Rosenwirth, Brigitte ^b,d   Arnold, Edward ^a  

^a RUTGERS UNIVERSITY   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c Oxford Veterinary Labs   (United States)

^d BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

Author keywords

Antiviral agents; Crystallography; Synchrotron X radiation; Virus structure; Virus ligand complexes

Indexed keywords

ANTIVIRUS AGENT; BENZTHIAZIDE; SDZ 880061; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; CYTOTOXICITY; HUMAN; HUMAN CELL; HUMAN RHINOVIRUS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RHINOVIRUS; SYNCHROTRON; VIRUS INHIBITION; VIRUS MORPHOLOGY; VIRUS REPLICATION; X RAY ANALYSIS;

HUMAN RHINOVIRUS 14; HUMAN RHINOVIRUS SP.; MIRIDAE; RHINOVIRUS;

EID: 0030012893     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1996.0307     Document Type: Article

References (65)

1. Acharya, R., Fry E., Stuart, D., Fox, G., Rowlands, D. & Brown, F. (1989). The three-dimensional structure of foot-and-mouth disease virus at 2.9 Å resolution. Nature, 337, 709-716.
2. Andries, K., Dewindt, B., De Brabander, M., Stokbroekx, R. & Janssen, P. A. J. (1988). In vitro activity of R 61837, a new antirhinovirus compound. Arch. Virol. 101, 155-167.
3. Andries, K., DeWindt, B., Snoeks, J., Wouters, L., Moereels, H., Lewi, P. J. & Janssen, P. A. J. (1990). Two groups of rhinoviruses revealed by a panel of antiviral compounds present sequence divergence and differential pathogenicity. J. Virol. 64, 1117-1123.
4. Andries, K., DeWindt, B., Snoeks, J., Willebrords, R., van Eemeren, K., Stokbroekx, R. & Janssen, P. A. J. (1992). In vitro activity of pirodavir (R 77975), a substituted phenoxy-pyridazinamine with broad-spectrum antipicornaviral activity. Antimicrob. Agents Chemother. 36, 100-107.
5. Arnold, E. & Rossmann, M. G. (1988). The use of molecular-replacement phases for the refinement of the human rhinovirus 14 structure. Acta Crystallog. sect. A, 44, 270-282.
6. Arnold, E. & Rossmann, M. G. (1990). Analysis of the structure of a common cold virus, human rhinovirus 14, refined at a resolution of 3.0 Å. J. Mol. Biol. 211, 763-801.
7. Arnold, E., Erickson, J. W., Fout, G. S., Frankenberger, E. A., Hecht, H.-J., Luo, M., Rossmann, M. G. & Rueckert, R. R. (1984). Virion orientation in cubic crystals of the common cold virus HRV14. J. Mol. Biol. 177, 417-430.
8. Arnold, E., Vriend, G., Luo, M., Griffith, J. P., Kamer, G., Erickson, J. W., Johnson, J. E. & Rossmann, M. G. (1987). The structure determination of a common cold virus, human rhinovirus 14. Acta Crystallog. sect A, 43, 346-361.
9. Badger, J., Minor, I., Kremer, M. J., Oliveira, M. A., Smith, T. J., Griffith, J. P., Guerin, D. M. A., Krishnaswamy, S., Luo, M., Rossmann, M. G., McKinlay, M. A., Diana, G. D., Dutko, F. J., Fancher, M., Rueckert, R. R. & Heinz, B. A. (1988). Structural analysis of a series of antiviral agents complexed with human rhinovirus 14. Proc. Natl Acad. Sci. USA, 85, 3304-3308.
10. Bauer, D. J., Selway, J. W. T., Batchelor, J. F., Tisdale, M., Caldwell, I. C. & Young, D. A. B. (1981). 4′,6-Dichloroflavan (BW683C), a new anti-rhinovirus compound. Nature, 292, 369-370.
11. Bibler-Muckelbauer, J. K., Kremer, M. J., Rossmann, M. G., Diana, G. D., Dutko, F. J., Pevear, D. C. & McKinlay, M. A. (1994). Human rhinovirus 14 complexed with fragments of active antiviral compounds. Virology, 202, 360-369.
12. Caldwell, J. M., Meakins, G. D., Jones, R. H., Kidd, T. R. & Prout, K. (1987). Structural features and crystallographic examination of 5-acetyl- and 5-trifluoroacetyl-2-(N,N-disubstituted amino) thiazoles. J. Chem. Soc., Perkin Trans. I, 11, 2305-2310.
13. Cambilleau, C. & Horjales, E. (1987). Tom: a FRODO sub-package. J. Mol. Graphics, 5, 174.
14. Chapman, M. S., Minor, I. & Rossmann, M. G., Diana, G. D. & Andries, K. (1991). Human rhinovirus 14 complexed with antiviral compound R 61837. J. Mol. Biol. 217, 455-463.
15. Colonno, R., Condra, J. H., Mizutani, S., Callahan, P. L., Davies, M. E. & Murcko, M. (1988). Evidence for the direct involvement of the rhinovirus canyon in receptor binding. Proc. Natl Acad. Sci. USA, 85, 5449-5453.
16. Conant, R. M. & Hamparian, V. V. (1968). Rhinoviruses: basis for a numbering system 1. HeLa cells for propagation and serologic procedures. J. Immunol. 100, 107-113.
17. Davies, D. R., Sheriff, S. & Padlan, E. A. (1988). Antibody-antigen complexes. J. Biol. Chem. 263, 10541-10544.
18. Diana, G. D., Salvador, U. J., Zalay E. S., Johnson, R. E., Collins, J. E., Johnson, D., Hinshaw, W. B., Lorenz, R. R., Thielking, W. H. & Pancic, F. (1977). Antiviral activity of some β-diketones. 1. Aryl alkyl diketones. In vitro activity against both RNA and DNA viruses. J. Med. Chem. 20, 750-756.
19. Diana, G. D., McKinlay, M. A., Brisson, C. J., Zalay, E. S., Miralles, J. V. & Salvador, U. J. (1985). Isoxazoles with antipicornavirus activity. J. Med. Chem. 28, 748-752.
20. Ding, J., Das, K., Moereels, H., Koymans, L., Andries, K., Janssen, P. A. J., Hughes, S. H. & Arnold, E. (1995). Structure of HIV-1 RT/TIBO R 86183 complex reveals similarity in the binding of diverse nonnucleoside inhibitors. Nature Struct. Biol. 2, 407-415.
21. Eggers, H. J. (1977). Selective inhibition of uncoating of echovirus 12 by rhodanine. Virology, 78, 241-252.
22. Erickson, J. W., Frankenberger, E. A., Rossmann, M. G., Fout, G. S., Medappa, K. C. & Rueckert, R. R. (1983). Crystallization of a common cold virus, human rhinovirus 14: "isomorphism" with poliovirus crystals. Proc. Natl Acad. Sci. USA, 80, 931-934.
23. Fox, M. P., McKinlay, M. A., Diana, G. D. & Dutko, F. J. (1991). Binding affinities of structurally related human rhinovirus capsid-binding compounds are related to their activities against human rhinovirus type 14. Antimicrob. Agents Chemother. 35, 1040-1047.
24. Fox, P. M., Otto, M. J. & McKinlay, M. A. (1986). Prevention of rhinovirus and poliovirus uncoating by WIN 51711, a new antiviral drug. Antimicrob. Agents Chemother. 30, 110-116.
25. Giranda, V. L., Heinz, B. A., Oliveira, M. A., Minor, I., Kim, K. M., Kolatkar, P. R., Rossmann, M. G. & Rueckert, R. R. (1992). Acid-induced structural changes in human rhinovirus 14: possible role in uncoating. Proc. Natl Acad. Sci. USA, 89, 10213-10217.
26. Golankiewicz, B., Januszczyk, P., Gdaniec, M. & Kosturkiewicz, Z. (1985). Reactions of acylaminocyanoesters with 2,4-bis(methoxyphenyl)-1,3,2,4-dithiadiphosphetane 2,4-disulfide leading to substituted aminothiazoles. Crystal structure of 5-aminothiazole-4-carboxylic acid ethyl ester. Tetrahedron, 41, 5989-5994.
27. Grant, R. A., Hiremath, C. N., Filman, D. J., Syed, R., Andries, K. & Hogle, J. M. (1994). Structures of poliovirus complexes with anti-viral drugs: implications for viral stability and drug design. Curr. Biol. 4, 784-797.
28. Greve, J. M., Davis, G., Meyer, A. M., Forte, C. P., Yost, S. C., Marlor, C. W., Kamarck, M. E. & McClelland, A. (1989). The major human rhinovirus receptor is ICAM-1. Cell, 56, 839-847.
29. Hadfield, A. T., Oliveira, M. A., Kim, K. H., Minor, I., Kremer, M. J., Heinz, B. A., Shepard, D., Pevear, D. C., Rueckert, R. R. & Rossmann, M. G. (1995). Structural studies on human rhinovirus 14 drug-resistant compensation mutants. J. Mol. Biol. 253, 61-73.
30. Heinz, B. A., Rueckert, R. R., Shepard, D. A., Dutko, F. J., McKinlay, M. A., Fancher, M., Rossmann, M. G., Badger, J. & Smith, T. J. (1989). Genetic and molecular analyses of spontaneous mutants of human rhinovirus 14 that are resistant to an antiviral compound. J. Virol. 63, 2476-2485.
31. Hogle, J. M., Chow, M. & Filman, D. J. (1985). Three-dimensional structure of poliovirus at 2.9 Å resolution. Science, 229, 1358-1365.
32. Ishitsuka, H., Ninomiya, Y. T., Ohsawa, C., Fujiu, M. & Suhara, Y. (1982). Direct and specific inactivation of rhinovirus by chalcone Ro 09-0410. Antimicrob. Agents Chemother. 22, 617-621.
33. Janin, J. & Chothia, C. (1990). The structure of protein-protein recognition sites. J. Biol. Chem. 265, 16027-16030.
34. Jones, T. A., Zou, J. Y., Cowan, S. W. & Kjeldgaard, M. (1991). Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallog. sect. A, 47, 110-119.
35. Kelley, J. L., Linn, J. A. & Selway, J. W. T. (1990). Antirhinovirus structure-activity relationships of 6-substituted-9-(4-methylbenzyl)-2-trifluoromethyl-9H-purines. Eur. J. Med. Chem. 25, 131-135.
36. Kim, S., Smith, T. J., Chapman, M. S., Rossmann, M. G., Pevear, D. C., Dutko, E. J., Felock, P. J., Diana, G. D. & McKinlay, M. A. (1989). Crystal structure of human rhinovirus serotype 1A (HRV 1A). J. Mol. Biol. 210, 91-111.
37. Kim, K. H., Willingmann, P., Gong, Z. X., Kremer, M. J., Chapman, M. S., Minor, I., Oliveira, M. A., Rossmann, M. G., Andries, K., Diana, G. D., Dutko, F. J., McKinlay, M. A. & Pevear, D. C. (1993). A comparison of the anti-rhinoviral drug binding pocket in HRV14 and HRV1A. J. Mol. Biol. 230, 206-227.
38. McKinlay, M. A., Pevear, D. C. & Rossmann, M. G. (1992). Treatment of the picornavirus common cold by inhibitors of viral uncoating and attachment. Annu. Rev. Microbiol. 46, 635-654.
39. Mian, I. S., Bradwell, A. R. & Olson, A. J. (1991). Structure, function and properties of antibody binding sites. J. Mol. Biol. 217, 133-151.
40. Nanni, R. G., Ding, J., Jacobo-Molina, A., Hughes, S. H. & Arnold, E. (1993). Review of HIV-1 reverse transcriptase three-dimensional structure: implications for drug design. Perspect. Drug Disc. Des. 1, 129-150.
41. Ninomiya, Y., Ohsawa, C., Aoyama, M., Umeda, I., Suhara, Y. & Ishitsuka, H. (1984). Antivirus agent Ro 09-0410 binds to rhinovirus specifically and stabilizes the virus conformation. Virology, 134, 269-276.
42. Oliveira, M. A., Zhao, R., Lee, W.-M., Kremer, M. J., Minor, I., Rueckert, R. R., Diana, G. D., Pevear, D. C., Dutko, F. J., McKinlay, M. A. & Rossmann, M. G. (1993). The structure of human rhinovirus 16. Structure, 1, 51-68.
43. Olson, N. H., Kolatkar, P. R., Oliveira, M. A., Cheng, R. H., Greve, J. M., McClelland, A., Baker, T. S. & Rossmann, M. G. (1993). Structure of a human rhinovirus complexed with its receptor molecule. Proc. Natl Acad. Sci. USA, 90, 507-511.
44. Otto, M. J., Fox, M. P., Fancher, M. J., Kuhrt, M. F., Diana, G. D. & McKinlay, M. A. (1985). In vitro activity of WIN 51711, a new broad-spectrum antipicornavirus drug. Antimicrob. Agents Chemother. 27, 883-886.
45. Palmenberg, A. C. (1989). Sequence alignments of picornaviral capsid proteins. In Molecular Aspects of Picornavirus Infection and Detection (Semler B. L. & Ehrenfeld, E., eds), pp. 211-241, Amer. Soc. Microbiology, Washington, DC.
46. Pevear, D. C., Fancher, M. J., Felock, P. J., Rossmann, M. G., Miller, M. S., Diana, G., Treasurywala, A. M., McKinlay, M. A. & Dutko, F. J. (1989). Conformational change in the floor of the human rhinovirus canyon blocks adsorption to HeLa cell receptors. J. Virol. 63, 2002-2007.
47. Rosenwirth, B. & Eggers, H. J. (1978a). Structure and replication of echovirus type 12. 1. Analysis of the polypeptides and RNA of echovirus 12 particles. Eur. J. Biochem. 92, 53-60.
48. Rosenwirth, B. & Eggers, H. J. (1978b). Structure and replication of echovirus type 12. 2. Viral polypeptides synthesized in the infected cell. Eur. J. Biochem. 92, 61-67.
49. Rosenwirth, B. & Eggers, H. J. (1979). Early processes of echovirus 12-infection: elution, penetration, and uncoating under the influence of rhodanine. Virology, 97, 241-255.
50. Rosenwirth, B., Kis, Z. L. & Eggers, H. J. (1995a). In vivo efficacy of SDZ 35-682, a new picornavirus capsid-binding agent. Antiviral Res. 26, 55-64.
51. Rosenwirth, B., Oren, D. A., Arnold, E., Kis, Z. L. & Eggers, H. J. (1995b). SDZ 35-682, a new picornavirus capsid-binding agent with potent antiviral activity. Antiviral Res. 26, 65-82.
52. Rossmann, M. G. (1979). Processing oscillation diffraction data for very large unit cells with an automatic convolution technique and profile fitting. J. Appl. Crystallog. 12, 225-238.
53. Rossmann, M. G. (1989). The canyon hypothesis: hiding the host cell receptor attachment site on a viral surface from immune surveillance. J. Biol. Chem. 264, 14587-14590.
54. Rossmann, M. G. (1994). Viral cell recognition and entry. Protein Sci. 3, 1712-1725.
55. Rossmann, M. G., Leslie, A. G. W., Abdel-Meguid, S. S. & Tsukihara, T. (1979). Processing and post-refinement of oscillation camera data. J. Appl. Crystallog. 12, 570-581.
56. Rossmann, M. G., Arnold, E., Erickson, J. W., Frankenberger, E. A., Griffith, J. P., Hecht, H.-J., Johnson, J. E., Kamer, G., Luo, M., Mosser, A. G., Rueckert, R. R., Sherry, B. & Vriend, G. (1985). Structure of a human common cold virus and functional relationships to other picornaviruses. Nature, 317, 145-153.
57. Rozhon, E., Cox, S., Buontempo, P., O'Connell, J., Slater, W., De Martino, J., Schwartz, J., Miller, G., Arnold, E., Zhang, A., Morrow, C., Jablonski, S., Pinto, P., Versace, R., Duelfer, T. & Girijavallabhan, V. (1993). SCH 38057: A picornavirus capsid-binding molecule with antiviral activity after the initial stage of viral uncoating. Antiviral Res. 21, 15-35.
58. Sanghvi, Y. S., Larson, S. B., Robins, R. K., Revankar, G. R., Gupta, P. K., George, R. D. & Dalley, N. K. (1988). Synthesis of certain exocyclic thiazole nucleosides related to thiazofurin. Formation of a unique acycloaminonucleoside. J. Heterocyclic Chem. 25, 623-633.
59. Smith, T. J., Kremer, M. J., Luo, M., Vriend, G., Arnold, E., Kamer, G., Rossmann, M. G., McKinlay, M. A., Diana, G. D. & Otto, M. J. (1986). The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science, 233, 1286-1293.
60. Staunton, D. E., Merluzzi, V. J., Rothlein, R., Barton, R., Marlin, S. D. & Springer, T. A. (1989). A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses. Cell, 56, 849-853.
61. Tisdale, M. & Selway, J. W. T. (1983). Inhibition of an early stage of rhinovirus replication by dichloroflavan (BW683C). J. Gen. Virol. 64, 795-803.
62. Wilson, I. A. & Stanfield, R. L. (1993). Antibody-antigen interactions. Curr. Opin. Struct. Biol. 3, 113-118.
63. Zeichardt, H., Otto, M. J., McKinlay, M. A., Willingmann, P. & Habermehl, K.-O. (1987). Inhibition of poliovirus uncoating by disoxaril (WIN 51711). Virology, 160, 281-285.
64. Zhang, A., Nanni, R. G., Oren, D. A., Rozhon, E. J. & Arnold, E. (1992). Three-dimensional structure-activity relationships for antiviral agents that interact with picornavirus capsids. Seminars Virol. 3, 453-471.
65. Zhang, A., Nanni, R. G., Li, T., Arnold, G. F., Oren, D. A., Jacobo-Molina, A., Williams, R. L., Kamer, G., Rubenstein, D. A., Li, Y., Rozhon, E., Cox, S., Buontempo, P., O'Connell, J., Schwartz, J., Miller, G., Bauer, B., Versace, R., Pinto, P., Ganguly, A., Girijavallabhan, V. & Arnold, E. (1993). Structure determination of antiviral compound SCH 38057 complexed with human rhinovirus 14. J. Mol. Biol. 230, 857-867.